Market Overview

Morning Market Movers

Share:
Related ALNY
Exclusive: Dicerna CEO Talks Goals For 2017, Competitors And Prospects Under Trump
Alnylam's Healthy Earnings Boost Price, Prompts Vetr Users To Call Hold
The Vetr community has downgraded $ALNY to 1.5-Stars (Vetr)
Related MRK
Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?
Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes
Should Merck, BMS Fear Roche's Drug Becoming The I-O King? (Seeking Alpha)

Alnylam Pharmaceuticals (NASDAQ: ALNY) rose 34.16% to $88.83 after the company reported that it has acquired investigational RNAi Therapeutic assets from Merck (NYSE: MRK). Genzyme and Alnylam expanded their collaboration on rare genetic diseases.

Rexahn Pharmaceuticals (NYSE: RNN) jumped 33.77% to $1.53. Rexahn Pharmaceuticals shares have jumped 235.29% over the past 52 weeks, while the S&P 500 index has gained 25.27% in the same period.

Rosetta Genomics (NASDAQ: ROSG) moved up 33.23% to $4.25 after the company reported that it has signed a master service provider agreement with a major global biopharmaceutical company.

Teche Holding Company (NYSE: TSH) shares jumped 28.44% to $70.00 after IBERIABANK (NASDAQ: IBKC) announced an agreement to acquire Teche Holding.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (ALNY + IBKC)

View Comments and Join the Discussion!